アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News Release

TagCyx announces the completion of 500 million Japanese Yen (US$ 4.9 Million, as of Aug. 31, 2016) private financing, led by The University of Tokyo Edge Capital as a lead investor, and SMBC Venture Capital, Nissay Capital CO., LTD. (Aug 2016)